Mwandishi:
ULY CLINIC
Mhariri:
ULY CLINIC
Imeboreshwa;
1 Machi 2026, 03:24:19
Iron Deficiency Anaemia
Iron Deficiency Anemia (IDA) is the most common nutritional anemia worldwide and results from insufficient iron availability for hemoglobin synthesis, leading to reduced red blood cell (RBC) production and microcytic hypochromic anemia.
Iron is essential for:
Hemoglobin synthesis
Myoglobin formation
Cellular respiration
Enzymatic processes
Iron deficiency occurs due to blood loss, increased physiological demand, inadequate intake, or impaired absorption.
Pathophysiology
Iron depletion progresses in three stages:
Iron store depletion (↓ ferritin)
Iron-deficient erythropoiesis (↓ serum iron, ↑ TIBC)
Iron deficiency anemia (↓ Hb, microcytosis)
Chronic deficiency results in impaired oxygen delivery and tissue hypoxia.
Risk Factors
Increased Blood Loss
Menorrhagia
Gastrointestinal bleeding (peptic ulcer, malignancy)
Hemorrhoids
Hookworm infestation
Frequent blood donation
Increased Demand
Pregnancy
Lactation
Infancy and adolescence (growth spurts)
Decreased Intake
Poor nutrition
Vegetarian/vegan diet without supplementation
Food insecurity
Malabsorption
Celiac disease
Inflammatory bowel disease
Post-gastrectomy
Chronic proton pump inhibitor use
Signs and Symptoms
General Symptoms
Fatigue
Weakness
Palpitations
Dizziness
Dyspnea on exertion
Headache
Characteristic Signs
Pallor (conjunctival, palmar)
Glossitis
Angular cheilitis
Koilonychia (spoon-shaped nails)
Pica (craving for non-food substances)
Brittle hair
Restless legs syndrome (sometimes)
Severe or chronic cases may lead to:
Tachycardia
Cardiac failure (rare but possible)
Diagnostic Criteria
Diagnosis is based on:
Microcytic hypochromic anemia
Laboratory evidence of iron deficiency
Identification of underlying cause
Clinical signs such as pallor, glossitis, koilonychia, and pica support the diagnosis.
Investigations
1. Complete Blood Count (CBC)
Low hemoglobin
Low MCV (<80 fL)
Low MCHC
Elevated RDW (anisocytosis)
2. Peripheral Blood Smear
Microcytic hypochromic RBCs
Pencil cells (elliptocytes)
Anisopoikilocytosis
3. Iron Studies
↓ Serum iron
↑ Total Iron Binding Capacity (TIBC)
↓ Transferrin saturation (<15%)
↓ Serum ferritin (most sensitive indicator)
Ferritin may be falsely normal or elevated in infection/inflammation.
4. Additional Investigations
Stool examination (hookworm, occult blood)
Upper and lower GI endoscopy (if GI bleeding suspected)
Celiac screening (if malabsorption suspected)
Pregnancy test (women of reproductive age)
Differential Diagnosis
Thalassemia trait
Anemia of chronic disease
Sideroblastic anemia
Lead poisoning
Distinguishing features:
Feature | IDA | Thalassemia Trait |
RDW | High | Normal |
Ferritin | Low | Normal |
RBC count | Low/Normal | Normal/High |
Treatment
Treatment consists of correcting iron deficiency and addressing the underlying cause.
Non-Pharmacological Management
Treat source of bleeding:
Menorrhagia
Peptic ulcer
GI malignancy
Hookworm infestation
Nutritional counseling
Iron-rich diet:
Red meat
Liver
Leafy greens
Legumes
Vitamin C to enhance iron absorption
Blood transfusion is reserved for:
Life-threatening anemia
Hemodynamic instability
Pharmacological Management
Oral Iron Therapy (First-Line)
Ferrous sulfate 200 mg PO every 8 hours (adults)Children: 5 mg/kg PO every 8 hours
Continue therapy for:
At least 3 months
And for 3 months after normalization of hemoglobin to replenish iron stores
Expected response:
Reticulocytosis within 7–10 days
Hb rise ~1 g/dL every 2–3 weeks
Parenteral Iron Therapy (If Indicated)
Indications:
Intolerance to oral iron
Malabsorption
Severe anemia needing rapid correction
Chronic kidney disease
Preparations include:
Iron sucrose
Ferric carboxymaltose
Monitoring
Hb after 2–4 weeks
Ferritin after completion of therapy
Evaluate compliance
Reassess for ongoing bleeding if poor response
Complications
Heart failure (severe cases)
Impaired cognitive development (children)
Preterm delivery (pregnancy)
Reduced work capacity
Increased infection susceptibility
Prevention
Iron supplementation in pregnancy
Deworming programs (endemic areas)
Nutritional education
Fortified foods
Screening high-risk groups
Management of chronic blood loss
Prognosis
Excellent with appropriate therapy
Recurrence likely if underlying cause untreated
Long-term monitoring required in chronic conditions
References
World Health Organization (WHO). Iron Deficiency Anaemia: Assessment, Prevention and Control.
Hoffbrand AV, Moss PAH. Essential Haematology. 8th ed.
Williams Hematology. 10th ed.
British Society for Haematology (BSH). Guidelines on Iron Deficiency Anemia.
National Institute for Health and Care Excellence (NICE). Anaemia Management Guidelines.
UpToDate. Iron deficiency in adults and children.
Ministry of Health Standard Treatment Guidelines (STG).
Rodak BF. Hematology: Clinical Principles and Applications.
O’Connell TX et al. Understanding iron deficiency anemia.
Camaschella C. Iron deficiency anemia. New England Journal of Medicine.
Updated on,
